The shortage of iodinated contrast media that has rattled U.S. radiology since early May didn’t come from nowhere.

The FDA is notifying patients and referrers of another breast-imaging service’s slide into noncompliance with regulatory standards for image quality.

The 40 evidence-based recommendations touch on everything from patient selection to study choice, radiation safety, clinical team dynamics, procedural techniques, study interpretations and more. 

A clinical trial pitting MRI against a burgeoning PET/CT technique has found the de facto defending champion better at revealing the presence of any grade of prostate cancer.

In the June 29 announcement, the ACR revealed CMS said the additional evidence provided to them was “insufficient” to support the reconsideration of their non-coverage decision.

Two emerging MRI techniques show promise as all-in-one imaging tests for patients with pain in and below the lower back due to changes in the sacroiliac joint.

Experts involved in the survey cautioned that the stagnancy of diversification is driving women and minorities away from the field completely, and efforts to change this are missing the mark. 

An imaging OEM is teaming with a multi-omics diagnostics company to offer lung-cancer care teams lab data alongside radiologic findings and clinical histories.